Status:
COMPLETED
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Lead Sponsor:
Cervel Neurotech, Inc.
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the efficacy of a Deep Shaped-Field repetitive transcranial magnetic stimulation (DSF-rTMS) system in the treatment of depression.
Eligibility Criteria
Inclusion
- Major depressive disorder (MDD)
- Mild to moderate level of resistance or intolerance to antidepressant treatment in the current episode.
- Will not become pregnant during study.
Exclusion
- Seizure disorder.
- History of brain injury or active CNS disease.
- Metal implants on or in brain, spinal cord, ear, eye or heart.
- Current use of proconvulsant medications (e.g., bupropion).
- Other significant psychiatric disorder.
- Substance use disorder (not including caffeine or nicotine).
- 7 or more failed treatment attempts for depression in one's lifetime.
- Have failed to clinically remit to an adequate trial of ECT or TMS.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01431001
Start Date
October 1 2011
End Date
October 1 2013
Last Update
May 19 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30306
2
Rush Medical College
Chicago, Illinois, United States, 60612
3
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
4
Monash Alfred Psychiatry Research Centre
Melbourne, Victoria, Australia, 3004